Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Capella BioScience

Capella BioScience
2014 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$15.6M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of monoclonal antibody medicines (mAbs) intended to discover, develop, and commercialize medicines based on mAbs therapeutics. The company's medicines leverage novel technologies to develop therapeutics, enabling researchers to research on the latest medical technology based drugs for oncology and autoimmune disease.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 158-160 North Gower Street
  • London NW1 2ND
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Capella BioScience’s full profile, request a free trial.

Capella BioScience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 08-Mar-2016 $15.6M 0000 Completed Startup
1. Seed Round 22-Dec-2014 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Capella BioScience Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OSE Immunotherapeutics Corporate Backed or Acquired Nantes, France 00 000.00 0000000000 000.00
0000000 Formerly PE-Backed Princeton, NJ 00 00000 00000000 00000
00000000 Venture Capital-Backed Heidelberg, Germany 00 0000 0000000000 0000
0000000 0000000 Venture Capital-Backed Amsterdam, Netherlands 00 0000 00000000000 0000
0000000 0000000000 Formerly VC-backed Heidelberg, Germany 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Capella BioScience Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Medicxi Venture Capital Minority 000 0000 000000 0
Osage University Partners Venture Capital Minority 000 0000 000000 0
Advent Life Sciences Venture Capital Minority 000 0000 000000 0
Data Collective Venture Capital Minority 000 0000 000000 0
Farzad Nazem Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Capella BioScience Executive Team (4)

Name Title Board
Seat
Contact
Info
Steve Holmes Ph.D Founder, Board Member & Chief Operating Officer
Rajesh Parekh Ph.D Clinical and Scientific Advisor
Donald Drakeman Ph.D Clinical and Scientific Advisor
Kevin Johnson Ph.D Clinical and Scientific Advisor

Capella BioScience Board Members (2)

Name Representing Role Since Contact
Info
Steve Holmes Ph.D Capella BioScience Founder, Board Member & Chief Operating Officer 000 0000
William Harrington MD Osage Venture Partners Board Observer 000 0000